1. Home
  2. TVTX vs LILA Comparison

TVTX vs LILA Comparison

Compare TVTX & LILA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • TVTX
  • LILA
  • Stock Information
  • Founded
  • TVTX 2008
  • LILA 2017
  • Country
  • TVTX United States
  • LILA Bermuda
  • Employees
  • TVTX N/A
  • LILA N/A
  • Industry
  • TVTX Biotechnology: Pharmaceutical Preparations
  • LILA Cable & Other Pay Television Services
  • Sector
  • TVTX Health Care
  • LILA Telecommunications
  • Exchange
  • TVTX Nasdaq
  • LILA Nasdaq
  • Market Cap
  • TVTX 1.8B
  • LILA 1.4B
  • IPO Year
  • TVTX N/A
  • LILA N/A
  • Fundamental
  • Price
  • TVTX $21.98
  • LILA $6.92
  • Analyst Decision
  • TVTX Strong Buy
  • LILA Buy
  • Analyst Count
  • TVTX 12
  • LILA 2
  • Target Price
  • TVTX $30.08
  • LILA $8.65
  • AVG Volume (30 Days)
  • TVTX 1.8M
  • LILA 441.5K
  • Earning Date
  • TVTX 02-20-2025
  • LILA 02-19-2025
  • Dividend Yield
  • TVTX N/A
  • LILA N/A
  • EPS Growth
  • TVTX N/A
  • LILA N/A
  • EPS
  • TVTX N/A
  • LILA N/A
  • Revenue
  • TVTX $233,175,000.00
  • LILA $4,456,900,000.00
  • Revenue This Year
  • TVTX $62.88
  • LILA $1.17
  • Revenue Next Year
  • TVTX $57.60
  • LILA $3.18
  • P/E Ratio
  • TVTX N/A
  • LILA N/A
  • Revenue Growth
  • TVTX 60.55
  • LILA N/A
  • 52 Week Low
  • TVTX $5.12
  • LILA $5.90
  • 52 Week High
  • TVTX $25.29
  • LILA $10.82
  • Technical
  • Relative Strength Index (RSI)
  • TVTX 53.52
  • LILA 51.83
  • Support Level
  • TVTX $22.48
  • LILA $6.17
  • Resistance Level
  • TVTX $23.69
  • LILA $7.64
  • Average True Range (ATR)
  • TVTX 1.22
  • LILA 0.32
  • MACD
  • TVTX -0.02
  • LILA 0.03
  • Stochastic Oscillator
  • TVTX 41.10
  • LILA 57.94

About TVTX Travere Therapeutics Inc.

Travere Therapeutics Inc is a biopharmaceutical company. The company is focused on identifying, developing and delivering life-changing therapies to people living with rare kidney, liver, and metabolic diseases. Its pipeline candidate, sparsentan, is an investigational product candidate in late-stage development for focal segmental glomerulosclerosis (FSGS) and IgA nephropathy (IgAN) - rare kidney disorders that often cause end-stage kidney disease.

About LILA Liberty Latin America Ltd.

Liberty Latin America Ltd is a telecommunications company. It is a provider of video, broadband internet, fixed-line telephony, and mobile services to residential and business customers. The company's reportable segments include C&W Caribbean, Liberty Networks, C&W Panama, VTR, Liberty Puerto Rico, and Liberty Costa Rica. The company generates the majority of its revenue from C&W Caribbean, and Liberty Puerto Rico segments.

Share on Social Networks: